Timothy L. Ratliff

Center for Cancer Research

Papers

1

Total Citations

43

H-Index

1

About

Timothy L. Ratliff is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the surgical management of kidney cancer. His primary research focuses on intraoperative imaging technologies and nephron-sparing surgical techniques, particularly in robot-assisted laparoscopic partial nephrectomy. Ratliff’s most notable contribution is his groundbreaking work on folate-targeted intraoperative fluorescence imaging using OTL38, a novel molecular imaging agent that enables real-time visualization of tumor margins during surgery. His seminal 2016 paper, "Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy," which has garnered 43 citations, demonstrated the first successful application of this technology in three human cases. This innovation directly addresses the critical challenge of achieving complete tumor resection while preserving healthy kidney tissue—a balance that determines both oncologic outcomes and renal function preservation. Ratliff’s work has been instrumental in establishing partial nephrectomy as the gold standard for small renal tumors, transforming surgical precision and patient outcomes. His research continues to shape the future of image-guided surgery in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
43
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases
43 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Center for Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago